Clinical Trial: Clinical Outcomes of Inhaled Amikacin in Ventilator Associated Pneumonia

U.S., Jan. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07369336) titled 'Clinical Outcomes of Inhaled Amikacin in Ventilator Associated Pneumonia' on Dec. 08, 2025.

Brief Summary: Article: Clinical Outcomes of Inhaled Amikacin in Ventilator-Associated Pneumonia: A group randomized controlled,add-on trial English:Patients in intensive care units often need ventilators to breathe. Sadly, these machines sometimes cause serious lung infections, known as ventilator-associated pneumonia (VAP). This study tested whether giving the antibiotic amikacin by inhalation (so itgoes straight into the lungs) could improve recovery when added to regular treatment. Researchers looked at how quickly infections cleared, how...